Navigation Links
Dutch Authorize Manufacture of Vaccinogen's New Cancer Vaccine; License Clears Path to European Production, Final FDA Trial
Date:5/7/2008

l in preventing a number of infectious diseases.

About Vaccinogen

Vaccinogen is a biopharmaceutical company that develops and commercializes cancer vaccines and other immunotherapeutic products -- Turning Cancer on Itself(TM). Based in Frederick, MD, the company has a portfolio of product candidates for the treatment of cancer, infectious disease, autoimmune, anti-inflammatory diseases and fully human monoclonal antibodies in various stages of clinical development.

http://www.vaccinogeninc.com

Vaccinogen's online press kit: http://www.vaccinogeninc.com/press_kit.cfm

Contact:

Andrew L. Tussing

Vaccinogen

atussing@vaccinogeninc.com

301-668-8400


'/>"/>
SOURCE Vaccinogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Highly Promising Dutch Research Into Alzheimers Disease and Parkinsons Disease
2. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
3. Childrens Hospitals in Washington to Lobby Congress to Reauthorize SCHIP Now
4. American Physicians Capital, Inc. Authorizes Additional $20 Million Share Buyback
5. QLT Board authorizes exploration of strategic alternatives to enhance near- to mid-term shareholder value
6. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
7. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
8. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
9. Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs
10. Varian, Inc. Board Authorizes New $100 Million Stock Repurchase Program
11. 5,000 Northern California Nurses to Vote to Authorize Third Strike Against Sutter Chain
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Confusion Over Homeopathic Medicines in Alexa Ray Joel's Hospitalization Clarified by the American Association of Homeopathic Pharmacists (AAHP) 2Al Novak Elected Chairman of the Board of OrbusNeich Medical 2CMPI to Host Hill Briefing Tomorrow on Follow on Biologic Drugs for Media and Congressional Staff With Reps Eshoo and Rogers 51694 1CMPI to Host Hill Briefing Tomorrow on Follow on Biologic Drugs for Media and Congressional Staff With Reps Eshoo and Rogers 51694 2Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 1Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 2Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 3Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 4Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 5Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 1Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 2Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 3